Advertisement

Gestational diabetes and subclinical inflammation: Evaluation of first year postpartum outcomes

Published:September 14, 2011DOI:https://doi.org/10.1016/j.diabres.2011.08.024

      Abstract

      Aim

      The aim of this study was to evaluate the relationship between sublinical inflammation and glycemic status in patients with gestational diabetes mellitus (GDM).

      Methods

      Sixty-one patients with GDM and 40 healthy pregnant women were included in the study. Fasting blood glucose (FBG), insulin, high sensitivity C-reactive protein (hsCRP), lipid parameters and carotid artery intima-media thickness (CIMT) were measured. Fifty-five of the patients with GDM returned for a follow-up visit scheduled at 1-year post-partum. These patients were subjected to 75 g oral glucose tolerance test (OGTT) followed by an evaluation of metabolic and subclinical inflammatory parameters were evaluated.

      Results

      The mean FBG, insulin, homeostasis model assessment insulin resistance (HOMA-IR), triglyceride (TG), hsCRP levels and CIMT in the women with GDM were significantly higher than those in the control group. C-reactive protein and CIMT were positively correlated with insulin, HOMA-IR, glucose value at the time of the OGTT 50, prepregnancy body mass index, TG and FBG. Multivariate logistic regression analysis on patients with sustained hyperglycemia one-year postpartum revealed elevated hsCRP levels to be independent risk factors for the development of dysglycemia.

      Conclusions

      Elevated hsCRP levels could be predictors of progression to T2DM later in life in patients with GDM.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Diabetes Association
        Gestational diabetes mellitus.
        Diabetes Care. 2003; 26: 103-105
        • O'Sullivan J.B.
        Diabetes mellitus after GDM.
        Diabetes. 1991; 40: 131-135
        • Kim C.
        • Newton K.M.
        • Knopp R.H.
        Gestational diabetes and the incidence of type 2 diabetes: a systematic review.
        Diabetes Care. 2002; 25: 1862-1868
        • Carpenter M.W.
        • Coustan D.R.
        Criteria for screening tests for gestational diabetes.
        Am J Obstet Gynecol. 1982; 144: 768-773
        • Festa A.
        • D’Agostino Jr., R.
        • Howard G.
        • Mykkänen L.
        • Tracy R.P.
        • Haffner S.M.
        Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).
        Circulation. 2000; 102: 42-47
        • Ford E.S.
        Body mass index, diabetes, and C-reactive protein among US adults.
        Diabetes Care. 1999; 22: 1971-1977
        • Pickup J.C.
        • Mattock M.B.
        • Chusney G.D.
        • Burt D.
        NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.
        Diabetologia. 1997; 40: 1286-1292
        • Tsigos C.
        • Papanicolaou D.A.
        • Kyrou I.
        • Defensor R.
        • Mitsiadis C.S.
        • Chrousos G.P.
        Dose dependent effects of recombinant human interleukin-6 on glucose regulation.
        J Clin Endocrinol Metab. 1997; 82: 4167-4170
        • Stith R.D.
        • Luo J.
        Endocrine and carbohydrate responses to interleukin-6 in vivo.
        Circ Shock. 1994; 44: 210-215
        • Festa A.
        • D’Agostino R.
        • Howard G.
        • Mykkänen L.
        • Tracy R.P.
        • Haffner S.M.
        Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study.
        Kidney Int. 2000; 58: 1703-1710
      1. Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–51.

        • Cao J.J.
        • Arnold A.M.
        • Manolio T.A.
        • Polak J.F.
        • Psaty B.M.
        • Hirsch C.H.
        • et al.
        Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study.
        Circulation. 2007; 116: 32-38
        • Wang T.J.
        • Nam B.H.
        • Wilson P.W.
        • Wolf P.A.
        • Levy D.
        • Polak J.F.
        • et al.
        Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study.
        Arterioscler Thromb Vasc Biol. 2002; 22: 1662-1667
        • Kivimäki M.
        • Lawlor D.A.
        • Juonala M.
        Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults: the cardiovascular risk in Young Finns Study.
        Arterioscler Thromb Vasc Biol. 2005; 25: 2197-2202
        • Tremblay A.J.
        • Morrissette H.
        • Gagné J.M.
        • Bergeron J.
        • Gagné C.
        • Couture P.
        Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population.
        Clin Biochem. 2004; 37: 785-790
        • Howard G.
        • Sharrett A.R.
        • Heiss G.
        • Evans G.W.
        • Chambless L.E.
        • Riley W.A.
        • et al.
        Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound ARIC Investigators.
        Stroke. 1993; 24: 1297-1304
        • Buchanan T.A.
        • Kjos S.L.
        Gestational diabetes: risk or myth?.
        J Clin Endocrinol Metab. 1999; 84: 1854-1857
        • Catalano P.M.
        • Huston L.
        • Amini S.B.
        • Kalhan S.C.
        Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus.
        Am J Obstet Gynecol. 1999; 180: 903-916
        • Metzger B.E.
        • Cho N.H.
        • Roston S.M.
        • Radvany R.
        Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus.
        Diabetes Care. 1993; 16: 1598-1605
        • Schmidt M.I.
        • Duncan B.B.
        • Sharrett A.R.
        • Lindberg G.
        • Savage P.J.
        • Offenbacher S.
        • et al.
        Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study.
        Lancet. 1999; 353: 1649-1652
        • Pradhan A.D.
        • Manson J.E.
        • Rifai N.
        • Buring J.E.
        • Ridker P.M.
        C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
        JAMA. 2001; 286: 327-334
        • Kern P.A.
        • Ranganathan S.
        • Li C.
        • Wood L.
        • Ranganathan G.
        Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.
        Am J Physiol Endocrinol Metab. 2001; 280: 745-751
        • Freeman D.J.
        • Norrie J.
        • Caslake M.J.
        • Gaw A.
        • Ford I.
        • Lowe G.D.
        • et al.
        West of Scotland Coronary Prevention Study C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.
        Diabetes. 2002; 51: 1596-1600
        • Barzilay J.I.
        • Abraham L.
        • Heckbert S.R.
        • Cushman M.
        • Kuller L.H.
        • Resnick H.E.
        • et al.
        The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study.
        Diabetes. 2001; 50: 2384-2389
        • Festa A.
        • D’Agostino Jr., R.
        • Tracy R.P.
        • Haffner S.M.
        Insulin Resistance Atherosclerosis Study elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
        Diabetes. 2002; 51: 1131-1137
        • Wolf M.
        • Sandler L.
        • Hsu K.
        • Vossen-Smirnakis K.
        • Ecker J.L.
        • Thadhani R.
        First-trimester C-reactive protein and subsequent gestational diabetes.
        Diabetes Care. 2003; 26: 819-824
        • Retnakaran R.
        • Hanley A.J.
        • Raif N.
        • Connelly P.W.
        • Sermer M.
        • Zinman B.
        C-reactive protein and gestational diabetes: the central role of maternal obesity.
        J Clin Endocrinol Metab. 2003; 88: 3507-3512
        • Di Benedetto A.
        • Russo G.T.
        • Corrado F.
        • Di Cesare E.
        • Alessi E.
        • Nicocia G.
        • et al.
        Inflammatory markers in women with a recent history of gestational diabetes mellitus.
        J Endocrinol Invest. 2005; 28: 34-38
        • Di Cianni G.
        • Lencioni C.
        • Volpe L.
        • Ghio A.
        • Cuccuru I.
        • Pellegrini G.
        • et al.
        C-reactive protein and metabolic syndrome in women with previous gestational diabetes.
        Diabetes Metab Res Rev. 2007; 23: 135-140
        • Winzer C.
        • Wagner O.
        • Festa A.
        • Schneider B.
        • Roden M.
        • Bancher-Todesca D.
        • et al.
        Plasma adiponectin: insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus.
        Diabetes Care. 2004; 27: 1721-1727
        • Di Cianni G.
        • Miccoli R.
        • Volpe L.
        • Lencioni C.
        • Del Prato S.
        Intermediate metabolism in normal pregnancy and in gestational diabetes.
        Diabetes Metab Res Rev. 2003; 19: 259-270
        • Yudkin J.S.
        • Stehouwer C.D.
        • Emeis J.J.
        • Coppack S.W.
        C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?.
        Arterioscler Thromb Vasc Biol. 1999; 19: 972-978
        • Hirsch A.T.
        • Criqui M.H.
        • Treat-Jacobson D.
        • Regensteiner J.G.
        • Creager M.A.
        • Olin J.W.
        Peripheral arterial disease detection, awareness, and treatment in primary care.
        JAMA. 2001; 286: 1317-1324
        • Magyar M.T.
        • Szikszai Z.
        • Balla J.
        • Valikovics A.
        • Kappelmayer J.
        • Imre S.
        • et al.
        Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers.
        Stroke. 2003; 34: 58-63
        • Winbeck K.
        • Kukla C.
        • Poppert H.
        • Klingelhöfer J.
        • Conrad B.
        • Sander D.
        Elevated Creactive protein is associated with an increased intima to media thickness of the common carotid artery.
        Cerebrovasc Dis. 2002; 13: 57-63
        • Tarim E.
        • Yigit F.
        • Kilicdag E.
        • Bagis T.
        • Demircan S.
        • Simsek E.
        • et al.
        Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus.
        Ultrasound Obstet Gynecol. 2006; 27: 177-182
        • Brownlee M.
        Lilly Lecture 1993 Glycation and diabetic complications.
        Diabetes. 1994; 43: 836-841
        • Esposito K.
        • Nappo F.
        • Marfella R.
        • Giugliano G.
        • Giugliano F.
        • Ciotola M.
        • et al.
        Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.
        Circulation. 2002; 106: 2067-2072
        • Williams S.B.
        • Goldfine A.B.
        • Timimi F.K.
        • Ting H.H.
        • Roddy M.A.
        • Simonson D.C.
        • et al.
        Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo.
        Circulation. 1998; 97: 1695-1701
        • Mügge A.
        • Elwell J.H.
        • Peterson T.E.
        • Harrison D.G.
        Release of intact endothelium derived relaxing factor depends on endothelial superoxide dismutase activity.
        Am J Physiol. 1991; 260: 219-225
        • Rubanyi G.M.
        • Vanhoutte P.M.
        Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle.
        Am J Physiol. 1986; 250: 815-821